3

PRIMARY DOCUMENT

Company: LIGAND PHARMACEUTICALS INC
Filed: August 6, 2015
Period of Report: August 6, 2015
Accession Number: 0000886163-15-000091

View Document ↗ View on SEC.gov ↗